Cornerstone Advisors, LLC Amgen Inc Transaction History

Cornerstone Advisors, LLC

$2.51 Billion
Q3 2024

A detailed history of Cornerstone Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cornerstone Advisors, LLC holds 25,400 shares of AMGN stock, worth $6.94 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

25,400

Previous 22,900 10.92%

Holding current value

$6.94 Million

Previous $7.16 Million 14.38%

% of portfolio

0.33%

Previous 0.29%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $773,450 - $843,450	2,500 Added 10.92%	25,400 $8.18 Million
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $52,550 - $63,862	-200 Reduced 0.87%	22,900 $7.16 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $80,661 - $97,368	300 Added 1.32%	23,100 $6.57 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $409,120 - $461,535	-1,600 Reduced 6.56%	22,800 $6.57 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $830,870 - $1.03 Million	3,800 Added 18.45%	24,400 $6.56 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $4.41 Million - $5.22 Million	20,600 New	20,600 $4.57 Million
Q4 2021 May 11, 2022	SELL	$198.88 - $227.6 $3.38 Million - $3.87 Million	-17,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $233,580 - $259,140	-1,000 Reduced 5.56%	17,000 $4.14 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $4.88 Million - $5.69 Million	-22,000 Reduced 55.0%	18,000 $4.48 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $3.05 Million - $3.39 Million	13,000 Added 48.15%	40,000 $10.2 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $5.34 Million - $6.55 Million	27,000 New	27,000 $6.37 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors, LLC with notifications on news.

Account

Cornerstone Advisors, LLC Amgen Inc Transaction History